Brief report| Volume 42, ISSUE 11, P1238-1240, November 2014

Download started.


Clinical manifestations and prognostic factors of central line–associated candidemia

Published:September 17, 2014DOI:
      From 2009-2012, a total of 281 episodes of central line–associated candidemia were identified, and the overall incidence was 2.05 episodes per 1,000 hospital admissions. More than half of the patients were classified as older adults, with an age ≥65 years. Cancer was the most common underlying disease (n = 231, 82.2%). Twenty patients had polycandidal candidemia, and 94 had concomitant bacteremia. The overall in-hospital mortality rate was 50.9%, and a multivariable analysis showed that this rate was only significantly associated with a Charlson comorbidity index score >5, jaundice, no antifungal agent use, and use of mechanical ventilators.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Montagna M.T.
        • Caggiano G.
        • Lovero G.
        • De Giglio O.
        • Coretti C.
        • Cuna T.
        • et al.
        Epidemiology of invasive fungal infections in the intensive care unit: results of multicenter Italian survey (AURORA Project).
        Infection. 2013; 41: 645-653
        • Diekema D.
        • Arbefeville S.
        • Boyken L.
        • Kroeger J.
        • Pfaller M.
        The changing epidemiology of healthcare-associated candidemia over three decades.
        Diagn Microbiol Infect Dis. 2012; 73: 45-48
        • Ruan S.Y.
        • Hsueh P.R.
        Invasive candidiasis: an overview from Taiwan.
        J Formos Med Assoc. 2009; 108: 443-451
        • Wisplinghoff H.
        • Bischoff T.
        • Tallent S.M.
        • Seifert H.
        • Wenzel R.P.
        • Edmond M.B.
        Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.
        Clin Infect Dis. 2004; 39: 309-317
        • Kett D.H.
        • Azoulay E.
        • Echeverria P.M.
        • Vincent J.L.
        • Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators
        Candida bloodstream infections in intensive care unit: analysis of the extended prevalence of infection in intensive care unit study.
        Crit Care Med. 2011; 39: 665-670
        • Marriott D.J.
        • Playford E.G.
        • Chen S.
        • Slavin M.
        • Nguyen Q.
        • Ellis D.
        • et al.
        • Australian Candidaemia Study
        Determinants of mortality in non-neutropenic ICU patients with candidaemia.
        Crit Care. 2009; 13: R115
        • González de Molina F.J.
        • León C.
        • Ruiz-Santana S.
        • Saavedra P.
        • CAVAI Study Group
        Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysis.
        Crit Care. 2012; 16: R105
        • Slavin M.A.
        • Sorrell T.C.
        • Marriott D.
        • Thursky K.A.
        • Nguyen Q.
        • Ellis D.H.
        • et al.
        Candidaemia in adult cancer patients: risk for fluconazole-resistant isolates and death.
        J Antimicrob Chemother. 2010; 65: 1042-1051
        • Chen Y.C.
        • Chang S.C.
        • Luh K.T.
        • Hsieh W.C.
        Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years.
        J Antimicrob Chemother. 2003; 52: 71-77
        • Yang Y.L.
        • Wang A.H.
        • Wang C.W.
        • Cheng W.T.
        • Li S.Y.
        • Lo H.J.
        • et al.
        TSARY Hospitals. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
        Diagn Microbiol Infect Dis. 2008; 61: 175-180